# Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations

> **NCT03812172** · — · COMPLETED · sponsor: **Mathew S. Maurer, MD** · enrollment: 646 (actual)

## Conditions studied

- Amyloid Cardiomyopathy, Transthyretin-Related

## Interventions

- **DRUG:** 99mTc-PYP or 99m Tc-HDP

## Key facts

- **NCT ID:** NCT03812172
- **Lead sponsor:** Mathew S. Maurer, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-15
- **Primary completion:** 2024-06-12
- **Final completion:** 2024-12-13
- **Target enrollment:** 646 (ACTUAL)
- **Last updated:** 2025-11-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03812172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03812172, "Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03812172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*